The research has demonstrated that the administration of H. diminuta-pulsed (HD)-DCs can significantly ameliorate the severity and reduce the mortality of DSS-induced colitis, with an enhanced TH2 response and expression of TH2 cytokines such as IL-10, which is produced mainly by CD4+ T cells. The gene discussed is CD4; the disease is colitis.